title: Effect of mifepristone (RU 486) on concentrations of prostaglandin E-2 binding sites in the rat endometrium.
abstract: Progesterone implants in ovariectomized rats increased endometrial concentrations of PGE-2 receptors. The increase was completely inhibited by simultaneous daily injection (7.5 mg/kg) of mifepristone (RU 486). A single injection of mifepristone on the morning of Day 1 of pseudopregnancy (day of oestrus) decreased the amount of PGE-2 receptors found in the endometrium on Day 5 by 64%. This inhibitory effect probably resulted from the antiprogesterone activity of this compound since it was not counteracted by simultaneous treatment with dexamethasone, shown to reverse totally the antiglucocorticoid action of mifepristone. The inhibition by mifepristone lasted only for 1 day; endometrial PGE-2 receptor levels on Day 6 of pseudopregnancy returned to the high values present in controls. Under these conditions, administration of the mifepristone did not affect the plasma oestradiol and progesterone concentrations during the 1st week of pseudopregnancy. The administration of mifepristone on Days 2 and 3 of pseudopregnancy kept the endometrial PGE-2 receptor levels low, even by 4 days after the end of treatment. We therefore concluded that, in the rat, progesterone priming leading to uterine receptivity can be delayed, at least by 1 day. In contrast, interruption of the progesterone action for a longer period later during the early pseudopregnant period resulted in an altered subsequent evolution of the endometrium, in terms of acquisition of the PGE-2 binding sites.
authors.affiliation: Laboratoire de Physiologie de la Reproduction, Hôpital de Bicêtre, Bat. INSERM, le Kremlin Bicêtre, France.
authors.forename: D
authors.initials: D
authors.lastname: Martel
authors.forename: M N
authors.initials: MN
authors.lastname: Monier
authors.forename: D
authors.initials: D
authors.lastname: Roche
authors.forename: A
authors.initials: A
authors.lastname: Psychoyos
mesh_terms: D000818:Animals; D015232:Dinoprostone / Q000378:metabolism*; D004717:Endometrium / Q000032:analysis*; D004963:Estrenes / Q000494:pharmacology*; D005260:Female; D015735:Mifepristone; D010052:Ovariectomy; D011374:Progesterone / Q000494:pharmacology; D011372:Progestins / Q000037:antagonists & inhibitors*; D011555:Pseudopregnancy / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D011982:Receptors, Prostaglandin / Q000032:analysis / Q000187:drug effects*; D018078:Receptors, Prostaglandin E
chemical_list: D004963:Estrenes; D011372:Progestins; D011982:Receptors, Prostaglandin; D018078:Receptors, Prostaglandin E; D015735:Mifepristone; D011374:Progesterone; D015232:Dinoprostone